产品: BAIAP2L1 抗体
货号: DF3853
描述: Rabbit polyclonal antibody to BAIAP2L1
应用: WB IF/ICC
文献验证: WB
反应: Human, Mouse, Rat
预测: Pig, Bovine, Horse, Sheep, Rabbit, Dog, Chicken
蛋白号: Q9UHR4
RRID: AB_2836210

浏览相似产品>>

   规格 价格 库存
 50ul RMB¥ 1250 现货
 100ul RMB¥ 2300 现货
 200ul RMB¥ 3000 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
WB 1:500-1:1000, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human, Mouse, Rat
克隆:
Polyclonal
特异性:
BAIAP2L1 Antibody detects endogenous levels of total BAIAP2L1.
RRID:
AB_2836210
引用格式: Affinity Biosciences Cat# DF3853, RRID:AB_2836210.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

BAI1 associated protein 2 like 1; BAI1 associated protein 2 like protein 1; BAI1-associated protein 2-like protein 1; Baiap2l1; BI2L1_HUMAN; Brain specific angiogenesis inhibitor 1 associated protein 2 like protein 1; Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1; FLJ42275; Insulin receptor tyrosine kinase substrate; IRTKS;

抗原和靶标

免疫原:

A synthesized peptide derived from human BAIAP2L1, corresponding to a region within the internal amino acids.

基因/基因ID:

文献引用

1). Insulin Receptor Substrate p53 Ameliorates High-Glucose-Induced Activation of NF-κB and Impaired Mobility of HUVECs. Biomed Research International, 2021 (PubMed: 33506012) [IF=2.6]

Application: WB    Species: Human    Sample: HUVECs

Figure 1 A high D-glucose concentration affected the expression levels of IRSp53 and gal-3 in HUVECs. (a) The expression levels of IRSp53 and gal-3 in HUVECs treated with D-glucose at different concentration for 96 h were determined by Western blotting using β-actin as a loading control. NG: normal glucose (25 mM); H1: high glucose 1 (40 mM); H2: high glucose 2 (60 mM); H3: high glucose 3 (80 mM). (b) The expression levels of IRSp53 and gal-3 in HUVECs treated with 60 mM D-glucose for different times were determined by Western blotting using β-actin as a loading control. (c) The expression levels of IRSp53 and gal-3 in HUVECs treated with 60 mM D-glucose or 60 mM mannitol for 96 h were determined by Western blotting using β-actin as a loading control. NG: normal glucose (25 mM); HG: high glucose (60 mM); MN: mannitol (60 mM). The values are the mean ± SD of three independent experiments. ∗P < 0.05 vs. the NG group; ∗∗P < 0.01 vs. the NG group; ∗∗∗P < 0.001 vs. the NG group.

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.